Monsanto Company (MON) Stock Rating Lowered by Vetr Inc.

Monsanto Company (NYSE:MON) was downgraded by Vetr from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday. They presently have a $118.00 price target on the stock. Vetr‘s price target points to a potential upside of 3.68% from the company’s current price.

A number of other brokerages have also commented on MON. Zacks Investment Research upgraded shares of Monsanto Company from a “hold” rating to a “buy” rating and set a $128.00 price target on the stock in a research note on Tuesday, March 7th. Royal Bank of Canada began coverage on shares of Monsanto Company in a research note on Thursday, February 23rd. They issued a “sector perform” rating and a $118.00 price target on the stock. CLSA upgraded shares of Monsanto Company from an “underperform” rating to an “outperform” rating in a research note on Friday, January 6th. They noted that the move was a valuation call. Finally, Sanford C. Bernstein set a $105.00 price target on shares of Monsanto Company and gave the company a “neutral” rating in a research note on Thursday, January 5th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the stock. Monsanto Company currently has a consensus rating of “Buy” and an average price target of $116.15.

Analyst Recommendations for Monsanto Company (NYSE:MON)

Shares of Monsanto Company (NYSE:MON) opened at 113.81 on Tuesday. The firm has a market cap of $49.91 billion, a price-to-earnings ratio of 31.21 and a beta of 0.93. Monsanto Company has a 12-month low of $84.79 and a 12-month high of $116.04. The stock’s 50 day moving average is $111.17 and its 200 day moving average is $105.77.

Monsanto Company (NYSE:MON) last released its quarterly earnings data on Thursday, January 5th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.20. The company had revenue of $2.22 billion for the quarter. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The firm’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.11) earnings per share. Equities analysts expect that Monsanto Company will post $4.74 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, April 7th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.90%. The ex-dividend date of this dividend is Wednesday, April 5th. Monsanto Company’s dividend payout ratio (DPR) is presently 58.86%.

Your IP Address:

In other news, EVP Steven Mizell sold 2,525 shares of the company’s stock in a transaction that occurred on Tuesday, January 10th. The shares were sold at an average price of $108.56, for a total transaction of $274,114.00. Following the completion of the sale, the executive vice president now owns 43,711 shares of the company’s stock, valued at approximately $4,745,266.16. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Michael K. Stern sold 5,670 shares of the company’s stock in a transaction that occurred on Wednesday, January 25th. The stock was sold at an average price of $110.00, for a total transaction of $623,700.00. Following the sale, the chief executive officer now directly owns 20,534 shares of the company’s stock, valued at approximately $2,258,740. The disclosure for this sale can be found here. Corporate insiders own 0.79% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Mascoma Wealth Management LLC purchased a new stake in shares of Monsanto Company during the fourth quarter worth $115,000. JNBA Financial Advisors increased its stake in shares of Monsanto Company by 24.6% in the fourth quarter. JNBA Financial Advisors now owns 1,148 shares of the company’s stock worth $121,000 after buying an additional 227 shares during the period. First Bank & Trust purchased a new stake in shares of Monsanto Company during the fourth quarter worth $138,000. First Manhattan Co. increased its stake in shares of Monsanto Company by 5.6% in the third quarter. First Manhattan Co. now owns 1,369 shares of the company’s stock worth $139,000 after buying an additional 73 shares during the period. Finally, Israel Discount Bank of New York GFN purchased a new stake in shares of Monsanto Company during the fourth quarter worth $140,000. 75.18% of the stock is owned by institutional investors.

Monsanto Company Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

To view Vetr’s full report, visit Vetr’s official website.

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Snapchat: CEO Did Not Label India as Being Poor
Snapchat: CEO Did Not Label India as Being Poor
Credit Suisse Slashes Bonuses by 40%
Credit Suisse Slashes Bonuses by 40%
Daily Mail to Pay Melania Trump $3 Million
Daily Mail to Pay Melania Trump $3 Million
New York Approves Free College Tuition
New York Approves Free College Tuition
Obamacare Market in Iowa Hit Hard by Aetna
Obamacare Market in Iowa Hit Hard by Aetna
Study: First Diagnosis Often Times is Incomplete or Wrong
Study: First Diagnosis Often Times is Incomplete or Wrong


© 2006-2017 Ticker Report. Google+.